Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status and phase

Unknown
Phase 4

Conditions

Transient Tachypnea of Newborn

Treatments

Device: Nasal SIMV
Device: nasal CPAP

Study type

Interventional

Funder types

Other

Identifiers

NCT01499238
4

Details and patient eligibility

About

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Full description

We aimed to compare two types of ventilatory support in cases of transient tachypnea of newborn who are >35 gestational week.

Enrollment

40 estimated patients

Sex

All

Ages

2 hours to 3 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >35 gestational week
  • wetlung

Exclusion criteria

major congenital anomalies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

nasal SIMV
Active Comparator group
Description:
rate: 30-50/min, PIP: 16, PEEP: 4-6, fİO2: 40%
Treatment:
Device: Nasal SIMV
nasal CPAP
Active Comparator group
Description:
PEEP: 4-6 mmHg, Fio2: 40%
Treatment:
Device: nasal CPAP

Trial contacts and locations

2

Loading...

Central trial contact

Gamze Demirel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems